Yoshinao Oda

29.1k total citations
948 papers, 20.4k citations indexed

About

Yoshinao Oda is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Yoshinao Oda has authored 948 papers receiving a total of 20.4k indexed citations (citations by other indexed papers that have themselves been cited), including 410 papers in Oncology, 356 papers in Pulmonary and Respiratory Medicine and 266 papers in Surgery. Recurrent topics in Yoshinao Oda's work include Sarcoma Diagnosis and Treatment (184 papers), Pancreatic and Hepatic Oncology Research (96 papers) and Cancer Immunotherapy and Biomarkers (82 papers). Yoshinao Oda is often cited by papers focused on Sarcoma Diagnosis and Treatment (184 papers), Pancreatic and Hepatic Oncology Research (96 papers) and Cancer Immunotherapy and Biomarkers (82 papers). Yoshinao Oda collaborates with scholars based in Japan, United States and United Kingdom. Yoshinao Oda's co-authors include Masazumi Tsuneyoshi, Hidetaka Yamamoto, Yukihide Iwamoto, Kenichi Kohashi, Sadafumi Tamiya, Yoshihiko Maehara, Masao Tanaka, Shinichi Aishima, Yuichi Yamada and Akio Sakamoto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yoshinao Oda

905 papers receiving 20.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yoshinao Oda Japan	64	8.7k	7.7k	6.3k	4.4k	2.8k	948	20.4k
Antoîne Italiano France	67	9.0k 1.0×	9.2k 1.2×	4.0k 0.6×	2.6k 0.6×	2.2k 0.8×	618	17.5k
Arndt Hartmann Germany	76	6.0k 0.7×	4.9k 0.6×	8.7k 1.4×	6.4k 1.5×	4.5k 1.6×	715	21.0k
Alexander J. Lazar United States	77	8.9k 1.0×	9.2k 1.2×	6.5k 1.0×	1.8k 0.4×	2.9k 1.0×	448	21.1k
Masazumi Tsuneyoshi Japan	74	7.6k 0.9×	8.3k 1.1×	6.2k 1.0×	6.0k 1.4×	2.1k 0.7×	577	22.3k
Christopher L. Corless United States	86	5.9k 0.7×	17.0k 2.2×	6.3k 1.0×	9.9k 2.2×	3.1k 1.1×	321	31.0k
Silvana Pilotti Italy	68	6.6k 0.8×	5.3k 0.7×	5.1k 0.8×	2.7k 0.6×	2.7k 0.9×	294	16.2k
Raf Sciot Belgium	81	5.2k 0.6×	12.5k 1.6×	4.6k 0.7×	4.6k 1.0×	2.0k 0.7×	555	24.8k
Jae Y. Ro United States	83	7.6k 0.9×	10.4k 1.4×	6.6k 1.0×	7.7k 1.7×	3.1k 1.1×	595	24.2k
Jason L. Hornick United States	82	8.3k 1.0×	11.6k 1.5×	4.5k 0.7×	5.1k 1.2×	2.1k 0.7×	487	24.8k
George J. Netto United States	65	4.6k 0.5×	7.4k 1.0×	7.5k 1.2×	5.2k 1.2×	3.5k 1.2×	390	17.6k

Countries citing papers authored by Yoshinao Oda

Since Specialization

Citations

This map shows the geographic impact of Yoshinao Oda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshinao Oda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshinao Oda more than expected).

Fields of papers citing papers by Yoshinao Oda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshinao Oda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshinao Oda. The network helps show where Yoshinao Oda may publish in the future.

Co-authorship network of co-authors of Yoshinao Oda

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshinao Oda. A scholar is included among the top collaborators of Yoshinao Oda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshinao Oda. Yoshinao Oda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Takada, Kazuki, Fumihiko Kinoshita, Takaki Akamine, et al.. (2025). Significance of Tumor Microvasculature in the Tumor Microenvironment in Adenocarcinoma with EGFR Common Mutations. Annals of Surgical Oncology. 32(4). 3031–3039.

Yamamoto, Hidetaka, Rina Jiromaru, Takahiro Hongo, et al.. (2024). Immunohistochemical p16 overexpression and Rb loss correlate with high‐risk human papillomavirus infection in endocervical adenocarcinomas. Histopathology. 84(7). 1178–1191. 3 indexed citations

Tagawa, Tetsuzo, Naoki Haratake, Fumihiko Kinoshita, et al.. (2023). Preventive effect of tertiary lymphoid structures on lymph node metastasis of lung adenocarcinoma. Cancer Immunology Immunotherapy. 72(6). 1823–1834. 33 indexed citations

Takeda, Atsunobu, Nobuyo Yawata, Koji Kato, et al.. (2022). Panuveitis induced by donor-derived CD8+ T cells after allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia. American Journal of Ophthalmology Case Reports. 27. 101673–101673.

Kai, Masaya, Makoto Kubo, Mai Yamada, et al.. (2021). Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patients. Cancer Medicine. 10(5). 1605–1613. 10 indexed citations

Yamada, Mai, Makoto Kubo, Hidetaka Yamamoto, et al.. (2021). Effect of the 2013 ASCO-CAP HER2 Testing Guideline on the Management of IHC/HER2 2+ Invasive Breast Cancer. Anticancer Research. 41(8). 4143–4149. 1 indexed citations

Iseda, Norifumi, Shinji Itoh, Tomoharu Yoshizumi, et al.. (2021). Impact of Nuclear Factor Erythroid 2–Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status. Hepatology Communications. 6(4). 665–678. 14 indexed citations

Ishihara, Shin, Yuichi Yamada, Takeshi Iwasaki, et al.. (2020). PD‑L1 and IDO‑1 expression in undifferentiated pleomorphic sarcoma: The associations with tumor infiltrating lymphocytes, dMMR and HLA class I. Oncology Reports. 45(1). 379–389. 15 indexed citations

Kubo, Makoto, Nami Yamashita, Hidetaka Yamamoto, et al.. (2020). Comprehensive molecular profiling broadens treatment options for breast cancer patients. Cancer Medicine. 10(2). 529–539. 29 indexed citations

10.

Kawazoe, Tetsuro, Hiroshi Saeki, Eiji Oki, et al.. (2020). Autocrine Leukemia Inhibitory Factor Promotes Esophageal Squamous Cell Carcinoma Progression via Src Family Kinase-Dependent Yes-Associated Protein Activation. Molecular Cancer Research. 18(12). 1876–1888. 6 indexed citations

11.

Ito, Takamichi, Yumiko Kaku‐Ito, Maho Murata, et al.. (2019). Intra- and Inter-Tumor BRAF Heterogeneity in Acral Melanoma: An Immunohistochemical Analysis. International Journal of Molecular Sciences. 20(24). 6191–6191. 19 indexed citations

12.

Nakanishi, Ryota, Tomoko Jogo, Yuichiro Nakashima, et al.. (2018). Gastric Cancer of "Crawling Type" Detected by Additional Gastrectomy After Endoscopic Submucosal Resection. Anticancer Research. 38(4). 2335–2338. 2 indexed citations

13.

Yamamoto, Hidetaka, Takafumi Nakano, Torahiko Nakashima, et al.. (2015). Dual gain of HER2 and EGFR gene copy numbers impacts the prognosis of carcinoma ex pleomorphic adenoma. Human Pathology. 46(11). 1730–1743. 15 indexed citations

14.

Otsu, Hajime, Eiji Oki, Hiroyuki Kawano, et al.. (2015). Correlation of HER2 expression with clinicopathological characteristics and prognosis in resectable gastric cancer.. PubMed. 35(4). 2441–6. 20 indexed citations

15.

Zaitsu, Yoko, Eiji Oki, Koji Ando, et al.. (2014). Loss of Heterozygosity of PTEN (Encoding Phosphate and Tensin Homolog) Associated with Elevated HER2 Expression Is an Adverse Prognostic Indicator in Gastric Cancer. Oncology. 88(3). 189–194. 9 indexed citations

16.

Imada, Kenjiro, Masaki Shiota, Kenichi Kohashi, et al.. (2013). Mutual Regulation between Raf/MEK/ERK Signaling and Y-Box–Binding Protein-1 Promotes Prostate Cancer Progression. Clinical Cancer Research. 19(17). 4638–4650. 59 indexed citations

17.

Hashimoto, Kazuki, Hidetaka Yamamoto, Hideki Shiratsuchi, et al.. (2012). HER‐2/neu gene amplification in carcinoma ex pleomorphic adenoma in relation to progression and prognosis: a chromogenic in‐situ hybridization study. Histopathology. 60(6B). E131–42. 44 indexed citations

18.

Shiota, Masaki, Akira Yokomizo, Keijiro Kiyoshima, et al.. (2010). Foxo3a Suppression of Urothelial Cancer Invasiveness through Twist1, Y-Box–Binding Protein 1, and E-Cadherin Regulation. Clinical Cancer Research. 16(23). 5654–5663. 76 indexed citations

19.

Aoki, Daisuke, Yoshinao Oda, Satoshi Hattori, et al.. (2009). Overexpression of Class III β-Tubulin Predicts Good Response to Taxane-Based Chemotherapy in Ovarian Clear Cell Adenocarcinoma. Clinical Cancer Research. 15(4). 1473–1480. 55 indexed citations

20.

Matsunobu, Tomoya, Kazuhiro Tanaka, Tomoyuki Nakamura, et al.. (2006). The Possible Role of EWS-Fli1 in Evasion of Senescence in Ewing Family Tumors. Cancer Research. 66(2). 803–811. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact